| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.54 | 0.0008 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.24 | 0.002 |